Muscarinic receptor ligands and their therapeutic potential
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 3 (4) , 426-432
- https://doi.org/10.1016/s1367-5931(99)80063-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999
- Muscarinic Agonists with Antipsychotic-like Activity: Structure−Activity Relationships of 1,2,5-Thiadiazole Analogues with Functional Dopamine Antagonist ActivityJournal of Medicinal Chemistry, 1998
- Selective modulation of muscarinic receptor subtypes: therapeutic potentialEmerging Drugs, 1998
- Efficacy and safety of tolterodine in patients with detrusor instability: a dose‐ranging studyBritish Journal of Urology, 1998
- TolterodineDrugs, 1998
- Muscarinic agonists for the treatment of Alzheimer’s disease: progress and perspectivesExpert Opinion on Investigational Drugs, 1997
- Muscarinic Analgesics with Potent and Selective Effects on the Gastrointestinal Tract: Potential Application for the Treatment of Irritable Bowel SyndromeJournal of Medicinal Chemistry, 1997
- Discovery & development of selective M3 antagonists for clinical useLife Sciences, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine ReceptorsScience, 1992